Loading financial statements…
Import this data to Google Sheets with:
=jivedata("BWXT","financials")Full statements spill as a table. For one cell: =jivedata("BWXT","Revenue") or =jivedata("BWXT","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
BWXT • CIK 0001486957
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $2,496,309 | $2,703,654 | $3,198,425 | $3,513,970 |
| Income (Loss) from Equity Method Investments | $50,807 | $55,931 | $74,911 | $85,771 |
| Operating Income (Loss) | $383,059 | $380,607 | $404,459 | $426,234 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $321,400 | $348,720 | $398,120 | $429,455 |
| Income Tax Expense (Benefit) | $75,079 | $66,422 | $68,259 | $73,293 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $246,321 | $282,298 | $329,861 | $356,162 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $472 | $357 | $916 | $983 |
| Net Income (Loss) Attributable to Parent | $245,849 | $281,941 | $328,945 | $355,179 |
| Cost of Revenue | $1,875,716 | $2,048,447 | $2,465,566 | $2,465,566 |
| Research and Development Expense | $7,613 | $7,478 | $13,867 | $15,555 |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | — | — | $4,972 | $431 |
| Selling, General and Administrative Expense | $279,694 | $318,663 | $394,416 | $420,355 |
| Costs and Expenses | $2,164,057 | $2,378,978 | $2,868,877 | $3,173,507 |
| Investment Income, Interest | $2,359 | $2,554 | $3,893 | $12,008 |
| InterestExpenseNonoperating | — | $39,475 | $44,207 | $34,488 |
| Other Nonoperating Income (Expense) | $-61,659 | $-31,887 | $33,975 | $25,701 |
| Nonoperating Income (Expense) | — | — | $-6,339 | $3,221 |
| Weighted Average Number of Shares Outstanding, Basic | 91,619,156 | 91,572,674 | 91,566,280 | 91,690,175 |
| Weighted Average Number of Shares Outstanding, Diluted | 91,874,537 | 91,859,732 | 91,856,013 | 92,025,737 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 6,089 | 64,575 | 12,156 | -458,669 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 255,381 | 287,058 | 289,733 | 335,562 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $75,766 | $74,109 | $499,779 | $608,203 |
| Restricted Cash and Cash Equivalents | $2,858 | $2,785 | $3,085 | $8,000 |
| Property, Plant and Equipment, Net | $1,228,520 | $1,278,161 | $1,585,136 | $1,603,188 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $70,180 | $99,112 | $220,391 | $198,251 |
| Other Receivables, Net, Current | $16,339 | $53,199 | $67,858 | $88,979 |
| Goodwill | $297,020 | $287,362 | $500,860 | $494,922 |
| Deferred Income Tax Assets, Net | $16,332 | $6,569 | $12,275 | $5,882 |
| Equity Method Investments | $88,608 | $99,403 | $150,143 | $164,708 |
| Inventory, Net | $27,400 | $40,300 | $46,537 | $46,293 |
| Intangible Assets, Net (Excluding Goodwill) | $185,510 | $165,325 | $329,859 | $311,773 |
| Other Assets, Current | $64,322 | $89,380 | $66,078 | $50,877 |
| Other Assets, Noncurrent | $103,778 | $92,498 | $124,625 | $123,792 |
| Assets, Current | $817,801 | $929,997 | $1,560,354 | $1,710,037 |
| Assets | $2,747,065 | $2,869,924 | $4,271,495 | $4,423,130 |
| Long-term Debt, Excluding Current Maturities | $1,203,422 | $1,042,970 | $2,015,983 | $2,019,897 |
| Liability, Other Postretirement Defined Benefit Plan, Noncurrent | $18,466 | $16,515 | $78,460 | $77,902 |
| Accrued Environmental Loss Contingencies, Noncurrent | $90,575 | $94,225 | $100,278 | $103,880 |
| Liability, Defined Benefit Pension Plan, Noncurrent | $82,786 | $82,602 | $78,167 | $69,344 |
| Other Liabilities, Noncurrent | $43,469 | $79,007 | $93,578 | $104,687 |
| Liabilities | — | — | $3,038,483 | $3,088,981 |
| Long-term Debt, Current Maturities | $6,250 | $12,500 | $0 | $0 |
| Accounts Payable, Current | $126,651 | $158,077 | $141,289 | $212,881 |
| Employee-related Liabilities, Current | $64,544 | $77,234 | $117,641 | $86,290 |
| Other Accrued Liabilities, Current | $70,210 | $65,100 | $107,802 | $100,844 |
| Contract with Customer, Liability | $107,391 | $161,290 | $305,285 | $305,285 |
| Liabilities, Current | $375,046 | $474,201 | $672,017 | $713,271 |
| Common Stock, Value, Issued | $1,281 | $1,283 | $1,288 | $1,289 |
| Preferred Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Additional Paid in Capital, Common Stock | $206,478 | $228,889 | $159,884 | $183,530 |
| Retained Earnings (Accumulated Deficit) | $2,093,917 | $2,287,151 | $2,523,631 | $2,653,709 |
| Treasury Stock, Common, Value | $1,360,862 | $1,388,432 | $1,432,943 | $1,452,744 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $-7,463 | $-48,211 | $-19,373 | $-51,334 |
| Stockholders' Equity Attributable to Parent | $933,351 | $1,080,680 | $1,232,487 | $1,334,450 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $-50 | $-276 | $525 | $-301 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $933,301 | $1,080,404 | $1,233,012 | $1,334,149 |
| Common Stock, Shares Authorized | 325,000,000 | 325,000,000 | 325,000,000 | 325,000,000 |
| Common Stock, Shares, Issued | 128,065,521 | 128,320,295 | 128,720,819 | 129,006,562 |
| Preferred Stock, Shares Authorized | 75,000,000 | 75,000,000 | 75,000,000 | 75,000,000 |
| Preferred Stock, Shares Issued | 0 | 0 | 0 | 0 |
| Treasury Stock, Common, Shares | 36,537,695 | 36,869,498 | 37,289,582 | 37,384,981 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $246,321 | $282,298 | $329,861 | $356,162 |
| Net Cash Provided by (Used in) Operating Activities | $363,701 | $408,428 | $479,848 | $519,158 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1,937 | $-2,126 | $-4,746 | $-768 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $40,625 | $-1,044 | $426,633 | $572,138 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $81,615 | $80,571 | $507,204 | $965,575 |
| Depreciation, Depletion and Amortization | $78,566 | $85,862 | $109,186 | $118,390 |
| Payments to Acquire Property, Plant, and Equipment | $151,286 | $153,647 | $184,557 | $202,396 |
| Income (Loss) from Equity Method Investments, Net of Dividends or Distributions | $-11,130 | $10,598 | $-19,139 | $-5,914 |
| Payments to Acquire Businesses, Net of Cash Acquired | $0 | $0 | $535,147 | $-3,037 |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | — | — | $4,972 | $431 |
| Payments to Acquire Investments | $2,343 | $0 | $0 | $0 |
| Deferred Income Taxes and Tax Credits | $-5,128 | $19,845 | $49,417 | $49,417 |
| Proceeds from Sale, Maturity and Collection of Investments | — | — | $3,397 | $0 |
| Share-based Payment Arrangement, Noncash Expense | $15,896 | $21,680 | $26,072 | $32,454 |
| Payments for (Proceeds from) Other Investing Activities | $8,009 | $717 | $-3,874 | $853 |
| Other Operating Activities, Cash Flow Statement | — | — | $-13,423 | $394 |
| Net Cash Provided by (Used in) Investing Activities | $-155,642 | $-154,561 | $-742,109 | $-197,068 |
| Repayments of Debt | — | — | $12,500 | $12,500 |
| Proceeds from Convertible Debt | — | — | $1,250,000 | $1,250,000 |
| Proceeds from Issuance of Other Long-term Debt | — | — | $1,030,000 | $1,030,000 |
| Repayments of Long-term Debt | $434,350 | $612,250 | $1,280,000 | $995,350 |
| Payments of Debt Issuance Costs | $0 | $0 | $33,494 | $33,494 |
| Payments for Repurchase of Common Stock | $0 | $20,000 | $30,000 | $0 |
| Payments of Ordinary Dividends, Common Stock | $84,974 | $88,349 | $92,467 | $96,113 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $7,592 | $7,570 | $13,624 | $20,273 |
| Payments for (Proceeds from) Derivative Instrument, Financing Activities | $-3,689 | $-19,591 | $-6,267 | $-14,873 |
| Proceeds from (Payments for) Other Financing Activities | $756 | $-207 | $1,333 | $3,948 |
| Net Cash Provided by (Used in) Financing Activities | $-169,371 | $-252,785 | $693,640 | $250,816 |
| Capital Expenditures Incurred but Not yet Paid | $7,105 | $17,537 | $12,295 | $17,552 |
| Increase (Decrease) in Accounts and Other Receivables | $-462 | $47,571 | $80,622 | $73,466 |
| Increase (Decrease) in Accounts Payable | $-9,025 | $34,532 | $-23,562 | $40,993 |
| Increase (Decrease) in Deposit Assets | $6,615 | $-21,514 | $12,644 | $21,591 |
| Increase (Decrease) in Income Taxes | $-4,786 | $1,650 | $-29,626 | $-51,514 |
| Increase (Decrease) in Other Accrued Liabilities | $-9,754 | $865 | $6,997 | $-16,613 |
| Increase (Decrease) in Other Operating Assets and Liabilities, Net | $8,861 | $13,829 | $174 | $-20,473 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $63,216 | $72,426 | $65,163 | $52,632 |
| Income Taxes Paid, Net | $84,478 | $45,508 | $47,892 | $74,331 |